Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
Immune cell engagers are engineered antibodies with at least one arm binding a tumor-associated antigen and at least another one directed against an activating receptor in immune effector cells: CD3 for recrui...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Antonio Tapia-Galisteo, Luis Álvarez-Vallina and Laura Sanz Tags: Review Source Type: research